Expanding Product Portfolio Altacor offers a diverse range of ophthalmic products, including dry eye treatments and surgical viscoelastics, creating opportunities to cross-sell to ophthalmologists and optometrists managing dry eye syndrome and cataract procedures.

European Market Growth The company's active expansion into European markets presents a prime opportunity for sales teams to target healthcare providers and distributors across new territories, leveraging recent product launches and partnerships.

Strategic Acquisition Fidia Pharma's recent acquisition of Altacor highlights its strategic value, paving the way for sales efforts directed at integrating Altacor’s products into broader pharmaceutical and eye care product lines within hospital and surgical settings.

Digital Engagement Tools The launch of Altacor Hub and digital marketing platforms indicates an openness to digital outreach and educational campaigns, enabling targeted B2B communications and increasing product awareness among eye care professionals.

Focused Niche Market Specializing in ocular surface disease and ophthalmic surgery allows sales teams to tailor their messaging to a focused professional audience, maximizing engagement with specialists who routinely prescribe or use dry eye and surgical viscoelastic products.